Noble Medichem Private Limited, a active private limited company, was established on 28 October 1992 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH1992PTC069250. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.14 Cr and a paid-up capital of ₹2.49 Cr.
Formerly known as Manali Hill Resorts Private Limited. It upholds a compliant status. Employing 186 professional, Its leadership includes Mihir Bakul Kapadia (Director), Anuj Dharmanath Pandey (Director), Vamesh Bhupendra Chovatia (Nominee Director). Past directors included Mihir Bakul Kapadia, Rima Mihir Kapadia, Veena Leslie Wellington. It holds ₹40.92 Cr open charges and ₹32.56 Cr settled loans. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3,Ground Floor,Hemu Castle Chs Ltd,, Dadabhai Road, Vile Parle West, Mumbai, Maharashtra, 400056.
U24100MH1992PTC069250
069250
28 October 1992
₹5.14 Cr
₹2.49 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Noble Medichem Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mihir Bakul Kapadia | Director | 29 Aug 2007 | Current |
| Anuj Dharmanath Pandey | Director | 04 Dec 2018 | Current |
| Vamesh Bhupendra Chovatia | Nominee Director | 18 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 May 2018 | Past |
| Pramod Abcsdd | Director | 10 Dec 2018 | Past |
| Pramod Abcsdd | Director | 30 Aug 2007 | Past |
| Pramod Abcsdd | Additional Director | 18 Apr 2024 | Past |
| Pramod Abcsdd | Director | 30 Aug 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Noble Medichem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.49% increase. The company also saw a substantial fall in profitability, with a 39.73% decrease in profit. The company's net worth Soared by an impressive increase of 22.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Noble Medichem had a public holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹409,161,832.00
₹325,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2024 | Yes Bank Limited | ₹15.00 Cr | Open |
| 18 Nov 2024 | Hdfc Bank Limited | ₹1.29 M | Open |
| 17 Aug 2024 | Hdfc Bank Limited | ₹8.00 M | Open |
| 26 Feb 2022 | Others | ₹24.65 Cr | Open |
| 24 Sep 2021 | Hdfc Bank Limited | ₹0.95 M | Open |
Explore comprehensive loan charge details -
Noble Medichem has a workforce of 186 employees as of Aug 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Noble Medichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Medichem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 24.65 Cr registered on 26 Feb 2022 with Charge ID 100552855 was modified on 27 Sep 2025. was completed.
A charge registered on 07 Oct 2023 via Charge ID 100814742 with Others was fully satisfied on 15 Apr 2025. was recorded as a recent event.
Progress on A charge registered on 22 Dec 2022 via Charge ID 100668979 with Others was fully satisfied on 03 Mar 2025. was documented.
Progress on A charge registered on 25 Jun 2019 via Charge ID 100285855 with Others was fully satisfied on 03 Mar 2025. was documented.
The activity A charge registered on 28 Feb 2019 via Charge ID 100244757 with Standard Chartered Bank was fully satisfied on 28 Feb 2025. was completed.
Progress on A charge registered on 19 Feb 2019 via Charge ID 100244748 with Standard Chartered Bank was fully satisfied on 28 Feb 2025. was documented.
The CIN of Noble Medichem Private Limited is U24100MH1992PTC069250.
Noble Medichem Private Limited is headquartered at 3,Ground Floor,Hemu Castle Chs Ltd,, Dadabhai Road, Vile Parle West, Mumbai, Maharashtra, 400056.
Noble Medichem Private Limited was incorporated on 28 October 1992.
The current directors of Noble Medichem Private Limited are
The primary industry of Noble Medichem Private Limited is Trade.
Noble Medichem Private Limited is unlisted.
The authorized capital of Noble Medichem Private Limited is ₹5.14 Cr, and the paid-up capital is ₹2.49 Cr.
The compliance status of Noble Medichem Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX